日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer

非致癌基因依赖性非小细胞肺癌的药物研发

Cruz, Pedro; Boixareu, Cristina; Silva, Diogo J; Ting, Joshua; Sena, Rayssa; Pang, Steph A; Mullings, Stephanie; Minchom, Anna

MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors

MDX-2001-101 研究方案:一项 I/IIa 期、多中心、首次人体试验、开放标签临床试验,评估 MDX2001 单药治疗晚期实体瘤患者的疗效

Dumbrava, Ecaterina; Minchom, Anna; Henry, Jason; Johnson, Melissa; Sommerhalder, David; Merchan, Jaime; Heist, Rebecca; Cabanas, Elena Garralda; Cotreau, Monette; Goenaga, Anne-Laure; Burzyn, Dalia; Makris, Lukas; Culm, Kerry; Abbadessa, Giovanni

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR

早期剂量探索性肿瘤试验中患者报告结局研究目标的国际共识驱动建议:OPTIMISE-ROR

Alger, Emily; Aiyegbusi, Olalekan Lee; Dueck, Amylou C; Minchom, Anna; Pe, Madeline; Peipert, John D; Snyder, Claire; Symeonides, Stefan N; Wilson, Roger; Basch, Ethan; Qiao, Yu; Bates, Susan E; Bulbeck, Helen; Dean, Lizzie; Di Maio, Massimo; Hansen, Aaron R; Kholmanskikh, Olga; Kobayashi, Ken; Landers, Dónal; Le Tourneau, Christophe; Lee, J Jack; Ma, Brigette B Y; Marshall, Lynley V; Patel, Sheetal; Petrie, Joan; Pond, Gregory R; Prior, Kieran; Rantell, Khadija R; Reeve, John F; Solovyeva, Olga; Wages, Nolan A; Weber, Harald A; Calvert, Melanie J; Yap, Christina

Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial

Defactinib联合avutometinib治疗实体瘤患者:1期FRAME试验

Banerjee, Susana; Krebs, Matthew G; Greystoke, Alastair; Garces, Alvaro Ingles; Perez, Vicky Sanchez; Terbuch, Angelika; Shinde, Rajiv; Caldwell, Reece; Grochot, Rafael; Rouhifard, Mahtab; Ruddle, Ruth; Gurel, Bora; Swales, Karen; Tunariu, Nina; Prout, Toby; Parmar, Mona; Symeonides, Stefan; Rekowski, Jan; Yap, Christina; Sharp, Adam; Paschalis, Alec; Lopez, Juanita; Minchom, Anna; de Bono, Johann Sebastian; Banerji, Udai

Treatment-related adverse events of antibody drug-conjugates in clinical trials

临床试验中抗体药物偶联物治疗相关的不良事件

Tan, Harold Nathan; Morcillo, Marta Ascanio; Lopez, Juanita; Minchom, Anna; Sharp, Adam; Paschalis, Alec; Silva-Fortes, Georgina; Raobaikady, Bindu; Banerji, Udai

First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors

首次在人体中研究钍-227标记的间皮素靶向抗体螯合剂偶联物(MSLN-TTC)在恶性间皮瘤和其他实体瘤患者中的疗效

Minchom, A; Lindén, O; Knapen, D G; Hassan, R; Lin, F I; Jalkanen, K; Subbiah, V; Tafuri, A; Ferreira, D; Jardine, V; Cleton, A; Pinkert, J; Bladt, F; Hennekes, H; Smit, E F

Barriers to publishing early phase clinical trials: the oncologists' perspective

早期临床试验发表的障碍:肿瘤学家的视角

Lucassen, Merel J J; Bergmann, Pedro; Husson, Olga; Banerji, Udai; Basu, Bristi; Melero, Ignacio; Calvo, Emiliano; Cassier, Philippe A; Drilon, Alexander; Fong, Peter C; Garralda, Elena; Joshua, Anthony M; Lin, Chia-Chi; Lopez, Juanita; Moreno, Victor; Minchom, Anna; Plummer, Ruth; Postel-Vinay, Sophie; Spreafico, Anna; Shimizu, Toshio; Yap, Timothy A; Yap, Christina; De Bono, Johann S; Steeghs, Neeltje

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

在难治性表皮生长因子受体突变型非小细胞肺癌中,皮下注射与静脉注射阿米伐他单抗联合拉泽替尼的疗效比较:来自 III 期 PALOMA-3 研究的主要结果

Leighl, Natasha B; Akamatsu, Hiroaki; Lim, Sun Min; Cheng, Ying; Minchom, Anna R; Marmarelis, Melina E; Sanborn, Rachel E; Chih-Hsin Yang, James; Liu, Baogang; John, Thomas; Massutí, Bartomeu; Spira, Alexander I; Lee, Se-Hoon; Wang, Jialei; Li, Juan; Liu, Caigang; Novello, Silvia; Kondo, Masashi; Tamiya, Motohiro; Korbenfeld, Ernesto; Moskovitz, Mor; Han, Ji-Youn; Alexander, Mariam; Joshi, Rohit; Felip, Enriqueta; Voon, Pei Jye; Danchaivijitr, Pongwut; Hsu, Ping-Chih; Silva Melo Cruz, Felipe José; Wehler, Thomas; Greillier, Laurent; Teixeira, Encarnação; Nguyen, Danny; Sabari, Joshua K; Qin, Angel; Kowalski, Dariusz; Şendur, Mehmet Ali Nahit; Xie, John; Ghosh, Debopriya; Alhadab, Ali; Haddish-Berhane, Nahor; Clemens, Pamela L; Lorenzini, Patricia; Verheijen, Remy B; Gamil, Mohamed; Bauml, Joshua M; Baig, Mahadi; Passaro, Antonio

Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study

曲妥珠单抗德鲁替康联合纳武利尤单抗治疗HER2表达阳性转移性乳腺癌或尿路上皮癌:Ib期DS8201-A-U105研究分析

Hamilton, Erika; Galsky, Matthew D; Ochsenreither, Sebastian; Del Conte, Gianluca; Martín, Miguel; De Miguel, Maria José; Yu, Evan Y; Williams, Anja; Gion, Maria; Tan, Antoinette R; Agrawal, Laila; Rutten, Annemie; Machiels, Jean-Pascal; Cresta, Sara; Debruyne, Philip R; Hennequin, Audrey; Moreno, Victor; Minchom, Anna; Valdes-Albini, Frances; Petrylak, Daniel; Li, Li; Tsuchihashi, Zenta; Suto, Fumitaka; Cheng, Fu-Chih; Kandil, Maha; Barrios, Daniel; Hurvitz, Sara

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的医疗服务:将患者报告结局纳入早期临床试验耐受性评估——专家虚拟圆桌会议的见解

Yap, Christina; Lee Aiyegbusi, Olalekan; Alger, Emily; Basch, Ethan; Bell, Jill; Bhatnagar, Vishal; Cella, David; Collis, Philip; Dueck, Amylou C; Gilbert, Alexandra; Gnanasakthy, Ari; Greystoke, Alastair; Hansen, Aaron R; Kamudoni, Paul; Kholmanskikh, Olga; King-Kallimanis, Bellinda L; Krumholz, Harlan; Minchom, Anna; O'Connor, Daniel; Petrie, Joan; Piccinin, Claire; Rantell, Khadija Rerhou; Rauz, Saaeha; Retzer, Ameeta; Rizk, Steven; Wagner, Lynne; Sasseville, Maxime; Seymour, Lesley K; Weber, Harald A; Wilson, Roger; Calvert, Melanie; Peipert, John Devin